Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
HIV-1 Integrase Structure and Function as a Therapeutic Target
Regulation of Glycosphingolipid Biosynthesis in Mouse Tissues
An Embodied, Augmented Reality Coding Platform for Pair Programming
I-Corps: Spatial computing learning system for early literacy development
Mating for Variety: Activity and Fitness in Pogonomyrmex Harvester Ants
Recently added grants:
The Opioid Crisis: The Effects and Unintended Consequences of State Policies on Opioid Analgesic Prescribing
Financial incentive strategies for smoking cessation in high-risk, hospitalized patients.
Therapeutic Dendritic Cell Vaccine for HIV
Exploring the Feasibility of a Peer-Driven Intervention to Improve HIV Prevention among Prisoners Who Inject Drugs
Psychostimulant-Induced Plasticity of Nucleus Accumbens Interneurons
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07156-15-0-1
Application #
7574918
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Suny Downstate Medical Center
$74,170
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Miller, Scott T. /
$142,726
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant